LB14. Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older

BACKGROUND: Older adults (≥65 years of age) remain at increased risk of influenza because they do not respond to standard dose influenza vaccines as well as younger adults. A high dose, inactivated trivalent influenza vaccine, IIV3-HD, containing four times the antigen content (60 µg hemagglutinin p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Lee-Jah, Meng, Ya, Janosczyk, Helene, Landolfi, Victoria, Talbot, H Keipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253668/
http://dx.doi.org/10.1093/ofid/ofy229.2188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253668/
http://dx.doi.org/10.1093/ofid/ofy229.2188

Ejemplares similares